Compared to Estimates, Medical Properties (MPW) Q4 Earnings: A Look at Key Metrics

Core Insights - Medical Properties reported a revenue of $231.84 million for the quarter ended December 2024, which is a significant decrease of 289.5% compared to the same period last year, but it exceeded the Zacks Consensus Estimate by 5.02% [1] - The earnings per share (EPS) for the quarter was $0.18, a notable improvement from -$1.11 in the previous year, and it surpassed the consensus EPS estimate of $0.16 by 12.50% [1] Revenue Breakdown - Straight-line rent revenue was reported at $43.70 million, exceeding the estimated $38.59 million, but reflecting a year-over-year decline of 126.2% [4] - Interest and other income amounted to $11.37 million, surpassing the average estimate of $9.75 million, yet showing a year-over-year decrease of 121.3% [4] - Rent billed revenue was $166.97 million, which was above the estimated $159.60 million, indicating a year-over-year increase of 112.9% [4] - Income from financing leases was reported at $9.82 million, slightly above the estimate of $9.80 million, but this represents a year-over-year decline of 49.4% [4] - The diluted net earnings per share were -$0.69, which was worse than the average estimate of -$0.13 [4] Stock Performance - Over the past month, shares of Medical Properties have returned +8.4%, contrasting with the Zacks S&P 500 composite's decline of -2.2% [3] - The stock currently holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the broader market in the near term [3]